Hormonal Contraceptives Differentially Suppress TFV and TAF Inhibition of HIV Infection and TFV-DP in Blood and Genital Tract CD4+ T cells
Abstract HIV prevention research is focused on combining antiretrovirals (ARV) and progestin contraceptives to prevent HIV infection and pregnancy. The possibility that progestins compromise ARV anti-HIV activity prompted us to evaluate the effects of progestins on tenofovir (TFV) and TFV-alafenamid...
Guardado en:
Autores principales: | Zheng Shen, Marta Rodriguez-Garcia, Mickey V. Patel, Jack Bodwell, Angela D. M. Kashuba, Charles R. Wira |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0e63fdb8ac994dd2924569421206fb6e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
- TAF Preventive Medicine Bulletin
-
Long-acting reversible hormonal contraception
por: N. E. Dahan-Farkas, et al.
Publicado: (2016) -
Important questions to ask when choosing hormonal contraception. Myths about contraception
por: Vera N. Prilepskaya, et al.
Publicado: (2021) -
Direct and Indirect endocrine-mediated suppression of human endometrial CD8+T cell cytotoxicity
por: Z. Shen, et al.
Publicado: (2021) -
The Contribution of Cervicovaginal Infections to the Immunomodulatory Effects of Hormonal Contraception
por: Raina N. Fichorova, et al.
Publicado: (2015)